Not available
Quote | Kuraray Co Ltd ADR (OTCMKTS:KURRY)
Last: | $34.04 |
---|---|
Change Percent: | 0.7% |
Open: | $34.04 |
Close: | $34.04 |
High: | $34.04 |
Low: | $34.04 |
Volume: | 297 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
News | Kuraray Co Ltd ADR (OTCMKTS:KURRY)
Calgon Carbon Ready to Assist Drinking Water Utilities to Meet New EPA Regulations on PFAS Levels PR Newswire EPA guidelines mandate PFOA & PFOS to 4 part per trillion and PFHxS, PFNA and HFPO-DA (GenX) to 10 ppt; Calgon Carbon's FILTRASORB ® Activated Carbon is...
Turnstone Biologics Corp. (TSBX) is expected to report $-0.73 for Q4 2023 Exro Technologies Inc (EXROF) is expected to report for Q4 2023 Boyd Gaming Corporation (BYD) is expected to report $1.43 for Q4 2023 Onto Innovation Inc. (ONTO) is expected to report $0.99 for Q4 2023 Motor...
Message Board Posts | Kuraray Co Ltd ADR (OTCMKTS:KURRY)
Subject | By | Source | When |
---|---|---|---|
Emylers: KURRY Financials 07/16/2014 20:20:12 Kuraray Co. Period Ending Total Revenue Cost of Revenu | Emylers | investorshangout | 07/17/2014 1:20:07 AM |
chartguy89: KURRY 33.8244 Stock Charts $KURRY 1 Month Chart | chartguy89 | investorshangout | 03/08/2014 9:52:23 AM |
chartguy89: KURRY Stock Charts Last: +0.10 Thursday, February 27, 2014 at 11:58:41 AM $KURRY | chartguy89 | investorshangout | 02/27/2014 4:58:53 PM |
News, Short Squeeze, Breakout and More Instantly...
Kuraray Co Ltd ADR Company Name:
KURRY Stock Symbol:
OTCMKTS Market:
Calgon Carbon Ready to Assist Drinking Water Utilities to Meet New EPA Regulations on PFAS Levels PR Newswire EPA guidelines mandate PFOA & PFOS to 4 part per trillion and PFHxS, PFNA and HFPO-DA (GenX) to 10 ppt; Calgon Carbon's FILTRASORB ® Activated Carbon is...
Turnstone Biologics Corp. (TSBX) is expected to report $-0.73 for Q4 2023 Exro Technologies Inc (EXROF) is expected to report for Q4 2023 Boyd Gaming Corporation (BYD) is expected to report $1.43 for Q4 2023 Onto Innovation Inc. (ONTO) is expected to report $0.99 for Q4 2023 Motor...
Epiroc AB ADR (EPOKY) is expected to report for Q3 2023 Sysmex Corporation ADR (SSMXY) is expected to report for Q2 2024 Streamline Health Solutions Inc. (STRM) is expected to report for Q1 2024 Helix Biopharma Corp. (HBPCF) is expected to report for Q2 2024 Standard Chartered plc...